Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Aug 27 2020

Full Issue

Research Roundup: COVID In Children; Diabetes; Gonorrhea; Broad-Spectrum Antibiotics

Each week, KHN compiles a selection of recently released health policy studies and briefs.

During the coronavirus disease 2019 (COVID-19) pandemic, determination of prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among children without symptoms of COVID-19 is critical to guide infection control policy. While estimates have been reported in children undergoing emergency surgery1 and oncologic care,2 these small studies have limited generalizability to large populations of children without symptoms. When children's hospitals resumed elective medical and surgical care in April and May 2020, many implemented routine SARS-CoV-2 testing for children presenting for care not associated with suspicion of COVID-19. Here, we report the prevalence of positive SARS-CoV-2 test results in children without symptoms at 28 children's hospitals across the US. (Marija Sola et al, 8/25)

This study reveals that children may be a potential source of contagion in the SARS-CoV-2 pandemic in spite of milder disease or lack of symptoms, and immune dysregulation is implicated in severe post-infectious MIS-C. (Yonker et al, 8/19)

Coronavirus disease 2019 (COVID-19) mortality is high in patients with hypertension, obesity, and diabetes. We examined the association between hypertension, obesity, and diabetes, individually and clustered as metabolic syndrome (MetS), and COVID-19 outcomes in patients hospitalized in New Orleans during the peak of the outbreak. (Xie et al, 8/1)

Also —

An analysis of gonococcal isolates collected in New York City in 2012 and 2013 showed that all large transmission clusters were susceptible to current gonorrhea therapies. In their analysis of genome sequences, antibiotic susceptibility, and patient data from 897 gonococcal isolates cultured by the New York City Public Health Laboratory from January 2012 through June 2014—a convenience sample that represents 1.5% of total gonorrhea infections in New York City during the period—the researchers found that the New York City gonococcal phylogeny reflected global diversity, with isolates from 22 of the 23 global Neisseria gonorrhea lineages.They also observed that the isolates clustered on the phylogeny by sexual behavior (P < 0.001), with one lineage significantly associated with isolates from men who have sex with men (MSM) and another associated with isolates from heterosexuals. They also clustered based on race and ethnicity (P < 0.001). (8/24)

Implementation of a core measure sepsis bundle by the Centers for Medicare and Medicaid Services (CMS) was associated with an immediate and long-term increase in the use of broad-spectrum antibiotics for hospital-onset multidrug-resistant (MDR) organisms, researchers reported late last week in Clinical Infectious Diseases. In the study, a team led by researchers from Virginia Commonwealth University evaluated monthly antibiotic data for four categories of antibiotics at 111 US hospitals before and after the 2015 implementation of the Sepsis Bundle Core Performance Measure for hospitals participating in Inpatient Quality Reporting (SEP-1). One element of the bundle is initiation of broad-spectrum antibiotics within 3 hours of sepsis diagnosis. The four antibiotic categories evaluated included antibiotics for surgical prophylaxis, broad-spectrum agents for community-acquired infections, broad-spectrum antibiotics for hospital-onset/MDR organisms, and anti–methicillin resistant Staphylococcus aureus agents. (8/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF